Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$262K Buy
+5,887
New +$257K 0.01% 1111
2024
Q2
Sell
-5,465
Closed -$219K 1296
2024
Q1
$219K Sell
5,465
-125
-2% -$4.7K 0.01% 1147
2023
Q4
$210K Sell
5,590
-3,000
-35% -$91.7K 0.01% 1115
2023
Q3
$239K Hold
8,590
0.01% 995
2023
Q2
$260K Hold
8,590
0.01% 968
2023
Q1
$264K Sell
8,590
-1,260
-13% -$48K 0.01% 922
2022
Q4
$370K Hold
9,850
0.01% 737
2022
Q3
$369K Buy
9,850
+3,684
+60% +$146K 0.01% 698
2022
Q2
$222K Sell
6,166
-793
-11% -$32.8K 0.01% 962
2022
Q1
$341K Hold
6,959
0.01% 814
2021
Q4
$333K Buy
6,959
+1,078
+18% +$51.1K 0.01% 847
2021
Q3
$258K Buy
+5,881
New +$249K 0.01% 922
2014
Q2
Sell
-3,219
Closed -$76K 628
2014
Q1
$76K Buy
+3,219
New +$78.3K 0.01% 580

Other funds holding SNV

Raymond James Trust's SNV Position: Q3 2024 in Review

Raymond James Trust opened a new position in Synovus (SNV) in Q3 2024: 5,887 shares worth $262K. The stake represents 0.01% of the portfolio and ranks #1111 among its holdings. This is a return to the name: Raymond James Trust previously reported a position in SNV as recently as Q1 2024.

Raymond James Trust first reported a position in SNV in Q1 2014 and has held it in 13 quarters since. The position peaked at $370K in Q4 2022. 433 funds tracked by Wall St. Rank hold SNV as of Q3 2024.

  • Raymond James Trust held 5,887 shares of Synovus worth $262K as of Q3 2024.
  • Synovus was a new Raymond James Trust position in Q3 2024.
  • Synovus made up 0.01% of Raymond James Trust's portfolio in Q3 2024, its #1111 holding.
  • Raymond James Trust first reported a position in Synovus in Q1 2014 and has held it in 13 quarters since.
  • Raymond James Trust's Synovus position peaked at $370K in Q4 2022.
  • 433 funds tracked by Wall St. Rank held Synovus as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.